Record revenue masks margin squeeze; order book strong but commodity headwinds persist
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
FY27 revenue guidance on track (₹2,500 Cr in 9M toward ₹4,500 Cr). Margin guidance maintained but commodity escalation gap suggests execution risk.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong order visibility (₹13 Cr book) and guidance held firm support multi-year growth, but Q2 PAT down 6.8% YoY despite 19% revenue growth exposes margin fragility. Commodity volatility (aluminum +40% Q1–Q2) unresolved; NGT suspension of Signature Global (₹15 Cr/month) is a material near-term headwind.
₹770.9 Cr
Revenue · +19.3% YoY₹47.6 Cr
Reported PAT · −6.8% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Highest ever quarterly revenue of ₹771 Cr; 19% YoY growth
METDelivered ₹770.9 Cr, YoY +19.3%. Supported by 13-Cr order book at Sept 2026.
EBITDA margin 15.5% Q2; PAT margin 6.1%; both on track
OVERSTATEDDelivered OPM 15.4%, NPM 6.1%, PAT ₹47.6 Cr vs ₹51 Cr Q2-FY26. Margin compression -6.8% YoY.
Order inflow ₹2,487 Cr in FY27 YTD; FY28 target ₹4,000 Cr achievable
METOrder book ₹13,013 Cr as of Sept 30; bid pipeline ₹3,270 Cr. FY27 run rate ~₹2,800 Cr annualized.
Commodity cost escalation mitigated by contractual pass-through; 100% private sector has pass-through
PartialManagement acknowledges 2% margin gap in Q1, narrowed in Q2. Aluminum formwork cost jumped 40% (₹10.5k→₹14.5k/sqm) but expects recovery. Gap still present.
Strong execution; working capital cycle reduced 11 days QoQ vs Q1
METContract assets ₹2,279 Cr (18–20% of prior 12M revenue), debtors ₹1,300 Cr. WC days fell from high levels but still elevated.
Earnings quality
What changed since the last call
Margin pressure acknowledged; commodity escalation gap narrowing
NeutralQ1 escalation gap was 35%; Q2 narrowed to 2% per MD. But absolute commodity prices (aluminum ₹14,500/sqm vs ₹10,500) remain elevated vs pre-war. No revision to 15.5–16.5% EBITDA guidance, but management flagged Q4 revisit if commodity volatility persists.
Order book quality upgrade; new client Mahindra Lifespace
UpgradeMahindra Lifespace added as large new client. Order book ₹13,013 Cr (Sept 30) vs ₹12,000+ Cr implied Q1. 54% public, 46% private — skew toward higher-margin private sector projects vs FY26.
NGT impact quantified; Signature Global suspended for ~15 days Q2
DowngradeNovember 5–20 embargo expected; ~20-day suspension per MD commentary. Run rate ₹15 Cr/month implies ₹7–10 Cr miss in Q3 if extended. Not new risk, but now framed as 'force measure,' likely to recur in Q4.
Working capital days improved 11 days vs Q1; debtors ₹1,300 Cr at 120-day cycle
UpgradeDebtors ECL provisioning normalized post-Q1. Total receivables (certified + unbilled) ₹2,400 Cr net basis, ~77–85% of 12M revenue (vs 18–20% contract asset ratio). Improvement trajectory sustained.
The Q&A
Analysts pressed hard on margin recovery path amid commodity volatility. MD held firm on 15.5–16.5% EBITDA guidance but conceded Q4 revisit likely. NGT risk questioned; MD downplayed near-term impact but acknowledged 'force measures.' Labor availability during elections raised; MD assured no impact seen yet. Working capital probed deeply; MD transparent on debtors, contract assets, and milestone billing delays. No evasion; tone remained confident but cautious.
Contract assets retention — Rajesh Jain, RK Capital
AnsweredRetention money ₹170 Cr steady. Contract assets increasing with revenue. Debtors at ₹1,300 Cr (~120 days). Total receivables ₹2,400 Cr net basis, ~77–85% of full-year guidance.
Project-wise contribution — Dhananjay Mishra, Centrum Broking
AnsweredCIDCO ₹178 Cr (can go up to ₹2 Cr/month). MHADA ₹123 Cr. Signature Global ₹95 Cr. Raymonds ₹100 Cr. Downtown ₹111 Cr. M3M ₹60 Cr. Combined MGCM Bhandup ₹63 Cr. Maldives ₹69 Cr.
Next two-quarter run rate & FY28 target — Dhananjay Mishra, Centrum Broking
PartialWe are positioned to cross ₹300 Cr quarterly run rate by Q4. FY28 target ₹4,000 Cr revenue already factored in. No pressure; bid pipeline ₹3,270 Cr.
Labor availability & elections impact — Tammay Jain, Dolat Capital
AnsweredIndia can't work >10 months/year due to elections. Q1 saw dip due to Bengal elections. We've factored ₹45–50 Cr revenue loss. No reason to change full-year targets.
Aluminum & commodity escalation — Tammay Jain, Dolat Capital
PartialTotal formwork purchase ₹64.2 Cr planned (₹127 Cr spent H1). Current aluminum ₹14,500/sqm vs ₹10,500 pre-war. Can come down to ₹12,000–12,500. No impact on PAT if government escalation clauses match market inflation.
Capex vs revenue growth alignment — Tammay Jain, Dolat Capital
AnsweredCapex directly proportional to order intake. Fixed asset turnover 4.7% maintained. Cash PAT margin within 10.5–11.5% target range. No reason to change guidance.
MHADA CIDCO run rate Q3–Q4 — Vasudev Ganatra, Nuvama
AnsweredCIDCO first 6M: ₹177 Cr, ~₹30 Cr/month. Expecting 35–40% increase Q3–Q4. Next year run rate not <₹50 Cr/month, implying ₹600 Cr FY27.
Signature Global NGT impact & recovery — Vasudev Ganatra, Nuvama
PartialSignature Global impacted by NGT. Run rate ₹15 Cr/month. Once Phase 1 ready (titanium excluded), should reach ₹18–19 Cr/month. Commodity gap narrowed in Q2 vs Q1.
FY27 revenue guidance reiteration — Parth Thakkar, JM Financial
AnsweredFY27 guidance maintained at ₹4,500 Cr. Already crossed ₹2,500 Cr in 9M. With bid pipeline ₹3,270 Cr, we are confident of surpassing guidance.
EBITDA margin & cash PAT margin guidance — Deepak Poddar, Sapphire Capital
AnsweredEBITDA margin guidance 15.5–16.5%. Cash PAT margin 10.5–11.25%. Both held firm if commodity escalation matches government WPI.
Bottom-line growth vs margin improvement — Deepak Poddar, Sapphire Capital
PartialLast year recovery from bad debt + non-core asset sale boosted H1 PAT. Company has assets ₹48 Cr for held sale in FY27. Margin profile next FY will show uptick.
Long-term margin strategy — Diwakar Rana, Prudent Equity
PartialCompany continues seeking profitable orders. Order mix strongly supports 15.5–16.5% EBITDA. Won't digress into low-margin infrastructure. Margin profile will improve next FY as Maldives project ramps.
Debt & leverage trajectory — Diwakar Rana, Prudent Equity
AnsweredDebt level ₹80 Cr invested in capex. Repayment ~₹10 Cr/month. By March 31, we'll see net debt fall in line with March 26 numbers. No significant buildup expected.
Public-private project mix & profitability — Parikshit Gupta, Fair Value Capital
AnsweredMix maintained at ~55% govt, 45% private. Ideally 55% govt, 45% private — project values higher in private sector (no sharing like public). Won't chase low-margin govt work.
Pledged shares & promoter commitment — Parikshit Gupta, Fair Value Capital
AnsweredNo change. Reduced pledge by ₹35 lakhs this year. Only 50 lakhs shares pledged left (vs ₹608 Cr initial limit). Safe pledge for working capital limits via SBI project-specific. No future pledges to NBFCs.
NBCC run rate & project specifics — Tammay Jain, Dolat Capital
AnsweredNBCC: crossed ₹60 Cr run rate; targeting ₹65–70 Cr/month. IIT Bombay: only location handed over ₹70 Cr against ₹550 Cr order. Expect full frontage by March 27; ₹60 Cr/quarter thereafter.
Water scarcity & construction delays — Dhananjay Mishra, Centrum Broking
AnsweredUrban area construction company. No major rain impact or water shortages yet. If drastic measures, we'll keep stakeholders informed.
CIDCO profitability delay — Rohit Gupta, RKG Online
DodgedBoard meeting cleared it. Hopefully next 10 days we'll share good news.
Organizational structure & CEO appointments — Rohit Gupta, RKG Online
AnsweredProjects getting complex. We appointed CEOs for 4 BUs (BU1, BU2, BU3, BU4) with revenue + profit targets. Dividing businesses into strategic units for accountability.
Non-core asset recovery — Mayank Kothari, ???
AnsweredHeld ₹48 Cr assets for sale in FY27. H1 physical recovery ₹5–6 Cr. Expect ₹52–54 Cr total by year-end. FY28: ₹100–150 Cr residual. Subject to pricing & settlement agreements.
Guidance
FY27 ₹4,500 Cr (from prior Q1 call)
HighAlready ₹2,500+ Cr in 9M; on track. Remaining ₹1,900–2,000 Cr in Q4 requires ₹475–500 Cr/month, achievable per MD.
FY28 ₹4,000+ Cr (implied from MD commentary)
MediumBid pipeline ₹3,270 Cr; target ₹1,000 Cr order inflow. MHADA ramp + CIDCO expansion + new wins support 40%+ growth path.
EBITDA margin 15.5–16.5% FY27
MediumQ2 at 15.5% (mid-band). Commodity escalation gap narrowed Q1→Q2 (35% → 2%). Dependent on WPI tracking contractual escalation; caveat added for Q4 revisit.
Cash PAT margin 10.5–11.25%
MediumQ2 PAT margin 6.1% (reported); cash PAT guidance excludes depreciation (₹35 Cr quarterly) and non-core items. Last-year comparison inflated by bad-debt recovery.
₹135–140 Cr total capex FY27 (budgeted)
HighH1 ₹127 Cr spent (₹64.2 Cr formwork, ₹10.57 Cr plant). Remaining ₹8–13 Cr in H2. Focus: aluminum formwork procurement & equipment for order execution.
Risks the call surfaced
Commodity inflation
HighAluminum formwork cost jumped 40% (₹10,500 → ₹14,500/sqm). Steel +30%. Contractual pass-through lagging; Q1 gap 35%, Q2 narrowed to 2%. If government WPI doesn't track market, margin miss on fixed-price contracts.
NGT suspension risk
HighNational Green Tribunal (NGT) suspended construction ~15 days in Q2 (Graphs 2, 3). MD indicated November 5–20 embargo expected, likely 20-day suspension. Signature Global run rate ₹15 Cr/month; suspension implies ₹7–10 Cr revenue miss per event. Recurrence likely in Q4 (elections period).
Working capital intensity
MediumContract assets at ₹2,279 Cr (18–20% of trailing 12M revenue). Debtors ₹1,300 Cr at 120-day cycle. Total receivables ₹2,400 Cr net = ~77–85% of full-year revenue guidance. Milestone billing delays on CIDCO (board clearance pending) compress H2 collections; working capital days may remain elevated.
Order execution & project delays
MediumCIDCO profitability realization delayed (board clearance pending per Rohit Gupta Q&A). IIT Bombay only location handed over (₹70 Cr vs ₹550 Cr order); land handover delays. NBCC run rate gradual ramp. If execution lags, Q3–Q4 revenue targets at risk.
Labor availability during elections
MediumUP elections in Q4 FY27 expected to reduce work availability. India cannot work >10 months/year due to election cycles. Q1 saw dip from Bengal elections. MD factored ₹45–50 Cr revenue loss; if election period extends, impact could exceed.
Management
Score 8/10. Clear, granular, well-structured. MD provided specific numbers on project run-rates, client mix, capex details. Transparent on challenges (NGT, commodities, delays). No evasion except on CIDCO profitability (board review pending). Strong track record on order book growth (₹13 Cr vs ₹12 Cr implied Q1). Revenue guidance on track (₹2,500 Cr in 9M toward ₹4,500 Cr). Margin guidance maintained but under pressure; working capital improving. One concern: profit growth lagging revenue (+13% H1 revenue vs -11% H1 PAT).
1 · Q3–Q4 FY27
MHADA ramp-up: 25 towers handed, INR 4,200–4,300 Cr revenue expected. Sector 8, 9 filing underway.
2 · Q3–Q4 FY27
CIDCO scope expansion: INR 177 Cr H1 run rate; targeting 35–40% increase in H2, INR 600 Cr FY27.
3 · Q3 FY27
Signature Global NGT suspension relief; return to ₹15 Cr/month run rate.
Commodity volatility (aluminum +40% Q1–Q2) unresolved; NGT suspension of Signature Global (₹15 Cr/month) is a material near-term headwind.
Informational and educational content only. Not investment advice.